{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:56:31Z","timestamp":1791050191162,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["NCOD-5D43TW008333"],"award-info":[{"award-number":["NCOD-5D43TW008333"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003437","name":"El Paso Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003437","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.expneurol.2019.113120","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:19:31Z","timestamp":1574075971000},"page":"113120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models"],"prefix":"10.1016","volume":"325","author":[{"given":"Guadalupe","family":"Vidal-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Segura-Ulate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Diaz-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Barragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"De-Leon Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vargas-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2019.113120_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1750-3639.2012.00637.x","article-title":"Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease","volume":"23","author":"Ahmed","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson's disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.expneurol.2019.113120_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ccr3.435","article-title":"Large-scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype","volume":"4","author":"Alsemari","year":"2015","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.expneurol.2019.113120_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/elps.201100335","article-title":"Bleach gel: a simple agarose gel for analyzing RNA quality","volume":"33","author":"Aranda","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.expneurol.2019.113120_bb0025","first-page":"261","article-title":"Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions and special considerations","volume":"12","author":"Ayzenberg","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.expneurol.2019.113120_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(94)90248-8","article-title":"Mitochondria respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy","volume":"125","author":"Blin Desnuelle","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0035","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0040","doi-asserted-by":"crossref","first-page":"601084","DOI":"10.1155\/2014\/601084","article-title":"Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases","volume":"2014","author":"Cai","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.expneurol.2019.113120_bb0045","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0050","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/jm9011802","article-title":"Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled Estrogen receptor GPR30","volume":"53","author":"Chinnasamy","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2019.113120_bb0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0014-4886(02)00017-1","article-title":"Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice","volume":"179","author":"Christianson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.2003.01657.x","article-title":"Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF","volume":"85","author":"Cohen","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2019.113120_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.26864","article-title":"Anhidrosis in multiple system atrophy involves pre- and postganglionic Sudomotor dysfunction","volume":"32","author":"Coon","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.113120_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0166-2236(02)02143-4","article-title":"Exercise: a behavioral intervention to enhance brain health and plasticity","volume":"25","author":"Cotman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0075","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.18632\/aging.101643","article-title":"Oxidative muscles have better mitochondrial homeostasis than glycolytic muscles throughout life and maintain mitochondrial function during aging","volume":"10","author":"Crupi","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.expneurol.2019.113120_bb0080","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2019.113120_bb0085","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2019.113120_bb0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1750-3639.1999.tb00553.x","article-title":"Multiple system atrophy: a sporadic synucleinopathy","volume":"9","author":"Dickson","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061988","article-title":"Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons","volume":"8","author":"Doi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2019.113120_bb0100","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1038\/tp.2015.179","article-title":"Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory","volume":"5","author":"Efstathopoulos","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.expneurol.2019.113120_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162162","article-title":"Preclinical metabolism, pharmacokinetics and in vivo analysis of new blood-brain-barrier penetrant Fingolimod analogues: FTY720-C2 and FTY720-Mitoxy","volume":"11","author":"Enoru","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2019.113120_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2019.113120_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(03)01403-0","article-title":"Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation","volume":"556","author":"Filipovska","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2019.113120_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00435","article-title":"Target RNAs strike Back on MicroRNAs","volume":"9","author":"Fuchs Wightman","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.expneurol.2019.113120_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2014.03.046","article-title":"Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid beta-induced memory impairment","volume":"268","author":"Fukumoto","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2019.113120_bb0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2019.113120_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0145","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jnr.22331","article-title":"Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior","volume":"88","author":"Graham","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/mcne.1995.1004","article-title":"The role of acetylcholine in regulating secretory responsiveness in rat sweat glands","volume":"6","author":"Grant","year":"1995","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2015.05.002","article-title":"Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype","volume":"271","author":"Heinen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","article-title":"Microglial activation parallels system degeneration in multiple system atrophy","volume":"63","author":"Ishizawa","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0170","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.3892\/mmr.2015.4120","article-title":"Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro","volume":"12","author":"Janssen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.expneurol.2019.113120_bb0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0180","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.26052","article-title":"Neuropathology of multiple system atrophy: new thoughts about pathogenesis","volume":"29","author":"Jellinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.113120_bb0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.29245\/2572.942X\/2016\/1.1002","article-title":"Recent advances in multiple system atrophy","volume":"1","author":"Jellinger","year":"2016","journal-title":"J. Neurol. Neuromed."},{"issue":"Suppl. 12","key":"10.1016\/j.expneurol.2019.113120_bb0190","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/mds.20537","article-title":"Grading of neuropathology in multiple system atrophy: proposal for a novel scale","volume":"20","author":"Jellinger","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.113120_bb0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2019.113120_bb0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00005072-199907000-00010","article-title":"Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy","volume":"58","author":"Kawamoto","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004010050004","article-title":"Glial cell line-derived neurotrophic factor-like immunoreactivity in the cerebella of normal subjects and patients with multiple system atrophy","volume":"100","author":"Kawamoto","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0210","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/jnen\/nly035","article-title":"Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain","volume":"77","author":"Kiely","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01819835","article-title":"The assessment of sudomotor dysfunction in multiple system atrophy","volume":"1","author":"Kihara","year":"1991","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005710","article-title":"GDNF overexpression from the native locus reveals its role in the Nigrostriatal dopaminergic system function","volume":"11","author":"Kumar","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2019.113120_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136575","article-title":"Involvement of peripheral nerves in the transgenic PLP-alpha-Syn model of multiple system atrophy: extending the phenotype","volume":"10","author":"Kuzdas-Wood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2019.113120_bb0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0012-1606(85)90136-8","article-title":"Neonatal treatment with nerve growth factor antiserum eliminates cholinergic sympathetic innervation of rat sweat glands","volume":"112","author":"Landis","year":"1985","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0235","first-page":"e55361","article-title":"Recombinant alpha- beta- and gamma-synucleins stimulate protein phosphatase 2A catalytic subunit activity in cell free assays","volume":"126","author":"Lek","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2019.113120_bb0240","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archneurol.2009.71","article-title":"Prospective differentiation of multiple system atrophy from parkinson disease, with and without autonomic failure","volume":"66","author":"Lipp","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0245","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","article-title":"Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo","volume":"285","author":"Lou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2019.113120_bb0250","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","article-title":"Alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy","volume":"35","author":"May","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2019.113120_bb0255","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2019.113120_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1740925X04000043","article-title":"Glial cell inclusions and the pathogenesis of neurodegenerative diseases","volume":"1","author":"Miller","year":"2004","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0265","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/mds.23318","article-title":"Callosal tissue loss in multiple system atrophy--a one-year follow-up study","volume":"25","author":"Minnerop","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.113120_bb0270","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","article-title":"Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy","volume":"11","author":"Monzio Compagnoni","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.expneurol.2019.113120_bb0275","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200526218","article-title":"Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720","volume":"35","author":"Morris","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0280","article-title":"Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy","volume":"3","author":"Nakamura","year":"2015","journal-title":"Acta Neuropathol. Communicat."},{"key":"10.1016\/j.expneurol.2019.113120_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00401-017-1772-0","article-title":"Multiple system atrophy: experimental models and reality","volume":"135","author":"Overk","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-5793(03)01168-2","article-title":"The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2","volume":"554","author":"Paugh","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2019.113120_bb2000","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0305","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0310","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","article-title":"Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Potenza","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2019.113120_bb0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fnmol.2017.00206","article-title":"Increased white matter inflammation in aging- and Alzheimer's disease brain","volume":"10","author":"Raj","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","article-title":"Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies","volume":"6","author":"Refolo","year":"2018","journal-title":"Acta neuropathologica Communicat."},{"key":"10.1016\/j.expneurol.2019.113120_bb0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/pmj.77.908.379","article-title":"Multiple system atrophy","volume":"77","author":"Rehman","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.expneurol.2019.113120_bb0330","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse Parkinsonian models","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0335","doi-asserted-by":"crossref","first-page":"B1015","DOI":"10.1093\/gerona\/59.10.B1015","article-title":"The effects of aging and treadmill running on soleus and gastrocnemius muscle morphology in the senescence-accelerated mouse (SAMP1)","volume":"59","author":"Sakakima","year":"2004","journal-title":"J. Gerontol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0340","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1749-6632.2001.tb03647.x","article-title":"Biomarkers of 3-nitropropionic acid (3-NPA)-induced mitochondrial dysfunction as indicators of neuroprotection","volume":"939","author":"Scallet","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: microglia and T cells get ready to tango","volume":"8","author":"Schetters","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1567202613666160823152446","article-title":"Fingolimod (FTY720) reduces cortical infarction and neurological deficits during ischemic stroke through potential maintenance of microvascular patency","volume":"13","author":"Schuhmann","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0355","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jphs.2017.02.006","article-title":"FTY720-derivatives do not induce FTY720-like lymphopenia","volume":"133","author":"Segura-Ulate","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0360","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2017.01.028","article-title":"FTY720 (Fingolimod) reverses alpha-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells","volume":"117","author":"Segura-Ulate","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2019.113120_bb0365","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","article-title":"Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy","volume":"25","author":"Shults","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0370","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2003.08.017","article-title":"Can the brain be protected through exercise? Lessons from an animal model of parkinsonism\u2606","volume":"184","author":"Smith","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2019.113120_bb0380","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10286-014-0266-6","article-title":"Animal models of multiple system atrophy","volume":"25","author":"Stefanova","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nan.12304","article-title":"Review: multiple system atrophy: emerging targets for interventional therapies","volume":"42","author":"Stefanova","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-003-0717-y","article-title":"Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)","volume":"106","author":"Stefanova","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0395","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0400","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial a-synucleinopathy: implications for multiple system atrophy","volume":"22","author":"Stefanova","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.113120_bb0405","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/jnr.22089","article-title":"Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy","volume":"87","author":"Ubhi","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2019.113120_bb0410","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","article-title":"Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors","volume":"30","author":"Ubhi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0415","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","article-title":"Multiple system atrophy: a clinical and neuropathological perspective","volume":"34","author":"Ubhi","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.expneurol.2012.01.008","article-title":"Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of alpha-synucleinopathy","volume":"234","author":"Ubhi","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0425","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ejn.12444","article-title":"Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96","volume":"39","author":"Ubhi","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.113120_bb0430","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ml500128g","article-title":"Novel FTY720-based compounds stimulate neurotrophin expression and phosphatase activity in dopaminergic cells","volume":"5","author":"Vargas-Medrano","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2019.113120_bb0435","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2018.10.040","article-title":"Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives","volume":"690","author":"Vargas-Medrano","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2019.113120_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107701","article-title":"FTY720-mitoxy reduces toxicity associated with alpha-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures","volume":"158","author":"Vargas-Medrano","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2019.113120_bb0445","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00415-006-0286-9","article-title":"Too hot to handle: heat stroke in multiple system atrophy","volume":"254","author":"Verstappen","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0450","doi-asserted-by":"crossref","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","article-title":"FTY720\/Fingolimod reduces synucleinopathy and improves gut motility in A53T mice: contributions of pro-brain-derived neurotrophic factor (pro-BDNF) and mature BDNF","volume":"291","author":"Vidal-Martinez","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2019.113120_bb0455","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.expneurol.2019.113120_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210888","article-title":"Iba-1-\/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions","volume":"14","author":"Waller","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2019.113120_bb0465","series-title":"Moving to a World Beyond \u201cp<0.05\u201d","first-page":"1","volume":"73","author":"Wasserstein","year":"2019"},{"key":"10.1016\/j.expneurol.2019.113120_bb0470","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.113120_bb0475","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuroscience.2012.01.028","article-title":"Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo","volume":"207","author":"Wu","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2019.113120_bb0480","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/ijmm.2013.1486","article-title":"Age-related decline of myelin proteins is highly correlated with activation of astrocytes and microglia in the rat CNS","volume":"32","author":"Xie","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.expneurol.2019.113120_bb0485","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","article-title":"Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration","volume":"45","author":"Yazawa","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2019.113120_bb0490","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2739\/kurumemedj.51.193","article-title":"Immunohistochemical localization of glial cell line-derived neurotrophic factor and its receptor ret in the rat sweat gland","volume":"51","author":"Yoshida","year":"2004","journal-title":"The Kurume Med. J."},{"key":"10.1016\/j.expneurol.2019.113120_bb0495","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/nu10081101","article-title":"The effect of diet on improved endurance in male C57BL\/6 mice","volume":"10","author":"Yu","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.expneurol.2019.113120_bb0500","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted Triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488619302675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488619302675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:50:11Z","timestamp":1762149011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488619302675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":101,"alternative-id":["S0014488619302675"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2019.113120","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2019.113120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113120"}}